Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intradermal Purified Vero Cell Rabies Vaccine with IMOJEV in 12–24 Month-old Children
TCTR20180531004Phase 4Active, not recruiting
- Sponsor
- Queen Saovabha Memorial Institute
- Start
- Mar 2015
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes, Viral Vector Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Purified Vero cell rabies vaccine, japanese encephalitis chimeric virus vaccine in rabies, Japanese encephalitis (JE), sponsored by Queen Saovabha Memorial Institute. Started Mar 2015; status: active, not recruiting.
02
Drugs
Purified Vero cell rabies vaccinejapanese encephalitis chimeric virus vaccine
03
Conditions
rabiesJapanese encephalitis (JE)
Beyond the preview
Go deeper on TCTR20180531004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180531004.